focus -WSS

focus

author：comprehensive 2025-09-29 01:34:59 - browse：36

Has PhRMA lost its fangs? Are 11th-hour changes ominous for clinical trials? And what’s next in pain medicine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The pharmaceutical industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. STAT Washington correspondent Rachel Cohrs joins us to explain the industry’s struggle to make headway — and how it factors into the 2024 election. We also discuss the latest news in the life sciences, including a twist in the future of Alnylam Pharmaceuticals, competition to Vertex Pharmaceuticals’ pain drug, and Gilead Sciences’ latest acquisition.

For more on what we cover, here’s all of Rachel’s coverage; here’s more on Vertex’s competition; here’s the news on Gilead; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Steward Health Care files for bankruptcy

WSS

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

BioAge raises $170M for combination therapy with Zepbound

How to improve immunocompromised access to mAb treatments

Medicare threatens to cut off funding for HCA's Mission hospital

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

explore

focus

focus

Guidelines to prevent youth baseball injuries need more muscle

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

At least 13 dead in Texas as scorching temps continue

Study: AI not yet building 'n

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden report: The neurospychology of memory and aging

Hollywood unions extend contract negotiations for actors

First recipient of genetically engineered pig kidney has died

Dobbs anniversary: the lost opportunity of abortion as health care

Elevance, private equity launch primary care company

knowledge

The dental labor crisis is a moment of opportunity

What we’ve learned from the Aduhelm mess

Gilead might be held responsible for not developing a drug

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Use wet bulb globe temperature, not heat index, to protect workers

BioAge raises $170M for combination therapy with Zepbound

focus

Wikipedia

focus

hotspot